About the Authors
- Manuela Barneo-Muñoz
-
Contributed equally to this work with: Manuela Barneo-Muñoz, Paula Juárez
Affiliations Program in Rare and Genetic Diseases and IBV/CSIC Associated Unit, Centro de Investigación Príncipe Felipe, Valencia, Spain, CIBER de Enfermedades Raras (CIBERER), ISCIII, Valencia and Madrid, Spain
- Paula Juárez
-
Contributed equally to this work with: Manuela Barneo-Muñoz, Paula Juárez
Affiliations Program in Rare and Genetic Diseases and IBV/CSIC Associated Unit, Centro de Investigación Príncipe Felipe, Valencia, Spain, CIBER de Enfermedades Raras (CIBERER), ISCIII, Valencia and Madrid, Spain
- Azahara Civera-Tregón
-
Affiliation Program in Rare and Genetic Diseases and IBV/CSIC Associated Unit, Centro de Investigación Príncipe Felipe, Valencia, Spain
- Laura Yndriago
-
Affiliation Program in Rare and Genetic Diseases and IBV/CSIC Associated Unit, Centro de Investigación Príncipe Felipe, Valencia, Spain
- David Pla-Martin
-
Affiliations Program in Rare and Genetic Diseases and IBV/CSIC Associated Unit, Centro de Investigación Príncipe Felipe, Valencia, Spain, CIBER de Enfermedades Raras (CIBERER), ISCIII, Valencia and Madrid, Spain
- Jennifer Zenker
-
Affiliation Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland
- Carmen Cuevas-Martín
-
Affiliations CIBER de Enfermedades Raras (CIBERER), ISCIII, Valencia and Madrid, Spain, Centro de Biología Molecular Severo Ochoa, UAM-CSIC, Madrid, Spain, Instituto de Investigación Hospital 12 de Octubre, Universidad Autónoma de Madrid, Madrid, Spain
- Anna Estela
-
Affiliations Program in Rare and Genetic Diseases and IBV/CSIC Associated Unit, Centro de Investigación Príncipe Felipe, Valencia, Spain, CIBER de Enfermedades Raras (CIBERER), ISCIII, Valencia and Madrid, Spain
- María Sánchez-Aragó
-
Affiliations CIBER de Enfermedades Raras (CIBERER), ISCIII, Valencia and Madrid, Spain, Centro de Biología Molecular Severo Ochoa, UAM-CSIC, Madrid, Spain, Instituto de Investigación Hospital 12 de Octubre, Universidad Autónoma de Madrid, Madrid, Spain
- Jerónimo Forteza-Vila
-
Affiliations Program in Rare and Genetic Diseases and IBV/CSIC Associated Unit, Centro de Investigación Príncipe Felipe, Valencia, Spain, Instituto Valenciano de Patología, Catholic University of Valencia, Valencia, Spain
- José M. Cuezva
-
Affiliations CIBER de Enfermedades Raras (CIBERER), ISCIII, Valencia and Madrid, Spain, Centro de Biología Molecular Severo Ochoa, UAM-CSIC, Madrid, Spain, Instituto de Investigación Hospital 12 de Octubre, Universidad Autónoma de Madrid, Madrid, Spain
- Roman Chrast
-
Affiliations Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland, Department of Neuroscience and Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Francesc Palau
-
* E-mail: fpalau@cipf.es
Affiliations Program in Rare and Genetic Diseases and IBV/CSIC Associated Unit, Centro de Investigación Príncipe Felipe, Valencia, Spain, CIBER de Enfermedades Raras (CIBERER), ISCIII, Valencia and Madrid, Spain, University of Castilla-La Mancha School of Medicine at Ciudad Real, Ciudad Real, Spain
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: MBM PJ JZ DPM JMC RC FP. Performed the experiments: MBM PJ ACT LY DPM JZ CCM AE. Analyzed the data: MBM PJ JZ DPM MSA JFV JMC RC FP. Wrote the paper: PJ JMC RC FP.